Long-term cognitive function change among breast cancer survivors

[1]  G. Bar-Sela,et al.  Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature , 2012, Breast Cancer Research and Treatment.

[2]  A. Asher.  Cognitive Dysfunction Among Cancer Survivors , 2011, American journal of physical medicine & rehabilitation.

[3]  Kai Gu,et al.  Quality of life after breast cancer diagnosis and survival. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Pierluigi Nicotera,et al.  Ageing, Neuronal Connectivity and Brain Disorders: An Unsolved Ripple Effect , 2011, Molecular Neurobiology.

[5]  Jing He,et al.  Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. , 2010, Archives of neurology.

[6]  Andrew J Saykin,et al.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  X. Shu,et al.  Exercise, tea consumption, and depression among breast cancer survivors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[9]  A. Vodermaier.  Breast Cancer Treatment and Cognitive Function: The Current State of Evidence, Underlying Mechanisms and Potential Treatments , 2009, Women's health.

[10]  S. Mohile,et al.  Geriatric assessment in older patients with breast cancer. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  C. Gross,et al.  Cognitive effects of hormonal therapy in older adults. , 2008, Seminars in oncology.

[12]  Blaise L. Worden,et al.  Cognitive Functioning and Aging in Women , 2007, Journal of women & aging.

[13]  I. Tannock,et al.  Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Ahles,et al.  Renaming “Chemobrain” , 2007, Cancer investigation.

[15]  S. Sereika,et al.  Cognitive impairment associated with adjuvant therapy in breast cancer , 2006, Psycho-oncology.

[16]  S. Allan,et al.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer , 2006, British Journal of Cancer.

[17]  I. Tannock,et al.  Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Meyers,et al.  Cancer as a risk factor for dementia: a house built on shifting sand. , 2005, Journal of the National Cancer Institute.

[19]  V. Shilling,et al.  The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. , 2005, Breast.

[20]  A. Rossi,et al.  Chemotherapy of breast cancer in the elderly. , 2005, Current medicinal chemistry.

[21]  A. Saykin,et al.  Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments , 2004, Current psychiatry reports.

[22]  S. Kagan,et al.  Nursing intervention and older adults who have cancer: specific science and evidence based practice. , 2004, The Nursing clinics of North America.

[23]  R. Theriault,et al.  The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma , 2004, Cancer.

[24]  B. Stewart,et al.  World Cancer Report , 2003 .

[25]  C. Loprinzi,et al.  Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. , 2002, Clinical breast cancer.

[26]  Hermann Brenner,et al.  Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis , 2002, The Lancet.

[27]  S. Sereika,et al.  Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. , 2001, Journal of pain and symptom management.

[28]  C. Brayne,et al.  Decline across different domains of cognitive function in normal ageing: results of a longitudinal population‐based study using CAMCOG , 2000, International journal of geriatric psychiatry.

[29]  Chetwyn C. H. Chan,et al.  Stroop Interference in Chinese and English , 2000, Journal of clinical and experimental neuropsychology.

[30]  A. Chan,et al.  Performance of 7- to 95-year-old individuals in a Chinese version of the category fluency test , 1999, Journal of the International Neuropsychological Society.

[31]  D. Salmon,et al.  Neuropsychological assessment of chinese elderly in the Shanghai dementia survey , 1995 .

[32]  Andrew J. Saykin,et al.  Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage , 2012, Breast Cancer Research and Treatment.

[33]  P. Reuter-Lorenz,et al.  Cognitive function and breast cancer: promise and potential insights from functional brain imaging , 2012, Breast Cancer Research and Treatment.

[34]  A. Argyriou,et al.  Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real. , 2011, Journal of pain and symptom management.